Oral Oncology
Volume 46, Issue 4 , Pages e25-e26, April 2010

Epidermal growth factor receptor (EGFR)-inhibitors, rashes, and survival: Is doxycycline the missing link?☆

VU University Medical Centre, De Boelelaan 1117, Amsterdam 1081 HV, Netherlands

Received 23 January 2010; received in revised form 4 February 2010; accepted 4 February 2010. published online 02 March 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ In regards to Shen et al., Oral Oncology 2009 Dec 24.

PII: S1368-8375(10)00047-3

doi:10.1016/j.oraloncology.2010.02.003

Oral Oncology
Volume 46, Issue 4 , Pages e25-e26, April 2010

Article Tools